drugset / Trial / NCT00940056

Totally Endoscopic Ablation of Atrial Fibrillation

NCT00940056

RandomizedParallel-groupOpen-labelTreatment

Summary

Primary Objective To evaluate the efficiency of totally endoscopic ablation of AF compared to rate control management of AF. Secondary Objectives Does totally endoscopic ablation: * reduce atrial fibrillation symptoms? * increase working capacity and improve quality of life? * improve atrial function? * reduce the risk for stroke?

Timeline

Start
2009-11
Primary completion
2014-05
Completion
2015-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Digoxin Other / unclassified

Indications